Insperity (NSP) Following Cautious Guidance Does Its Valuation Still Hold Up

Insperity (NSP) is back in focus after a third quarter update on October 29 that paired a small loss with cautious fourth quarter and full year 2026 earnings guidance, highlighting the company’s sensitivity to healthcare benefit costs.

Investors have pulled back after the update, with the share price falling 6.3% over the past week and slipping over the last quarter, even though Insperity still shows a 29% year to date share price gain and a 63.5% total shareholder return over 12 months. This is set against deeply negative 3 and 5 year total returns that hint at fragile momentum and a still cautious view of long term execution risk.

Spot opportunity in other HR and service providers facing similar cost pressures by scanning our curated list of list of solid balance sheet and fundamentals (25 results).

Insperity now trades only slightly below the average analyst target, while modelled fair value sits far lower. Is this a shallow dip in sentiment, or a sign the market still prices in too much optimism?

Most Popular Narrative: 3.7% Undervalued

Insperity closed at $49.82, while the analyst consensus Narrative on Simply Wall St points to a fair value of $51.75 using a 7.85% discount rate. As a result, the narrative frames the stock as modestly undervalued and driven by execution on margin repair and HRScale.

The guidance for 2026 adjusted EBITDA of US$185 million to US$225 million and adjusted EPS of US$1.88 to US$2.43, issued even as average paid worksite employees are expected to decline 1% to 1.6%, indicates that Insperity’s operating model is geared toward improving profit per worksite employee and potentially stronger earnings power if unit growth returns.

See why 6 investors see Insperity as 4% undervalued.

Result: Fair Value of $51.75 (UNDERVALUED)

Still, the narrative around Insperity can crack if healthcare and benefits costs flare up again or if HRScale uptake stalls, which would leave expenses harder to cover.

Find out about the key risks to this Insperity narrative.

Next Steps

Mixed sentiment around Insperity only matters if you let someone else make the call for you. Move quickly, check the underlying numbers yourself, then weigh up the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Insperity?

If you stop at Insperity, you risk missing other opportunities that fit your goals, risk profile, and timeline just as well or even better.

• Target resilient compounding potential by scanning a 31 resilient stocks with low risk scores that can help you focus on businesses with steadier profiles and fewer financial red flags.
• Hunt for mispriced quality by reviewing a curated pool of 40 high quality undervalued stocks that pair fundamentals with what may be appealing entry points.
• Aim to get ahead of the crowd by checking a focused group of 19 high quality undiscovered gems before attention and liquidity potentially move elsewhere.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com